Keywords: dimethaid, closes, 3m, rights, offer, canadian, specialty

Dimethaid closes C$9.3M rights offer

Article | 28 April 2003

Canadian specialty pharmaceutical developer, Dimethaid Research hassuccessfully completed its previously-announced rights offering. Rights were exercised for a total of 4,632,296 common ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dimethaid Research

3M

Go to company listing